Aripiprazole reduces severity of tics in children with Tourette's disorder

(Mary Ann Liebert, Inc./Genetic Engineering News) A meta-analysis of clinical trials evaluating the effectiveness of aripiprazole for the treatment of Tourette's disorder (TD) in children and adolescents showed a significantly greater overall improvement in total tics and tic severity from pretreatment to post-treatment for the aripiprazole compared to the placebo group. The drug was safe, with drowsiness, nausea, and headache being the most common adverse effects, according to the study published in Journal of Child and Adolescent Psychopharmacology.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news